Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Basal Cell Carcinoma (BCC) is a form of non-melanocytic skin cancer that arises from basal cells, the small, round cells present in the lower epidermis. Around 85% of BCCs occur on the face, head and neck. BCCs usually do not spread or metastasize to other parts of body, they become life threatening by metastasis only in extremely rare cases. According to the American Cancer Society, BCCs constitute around 80% of all non-melanoma skin cancers. Australia has been found to have the highest rate of basal cell carcinoma across the globe. Exposure to ultraviolet radiation is considered as the major cause behind BCC. Use of immunosuppressant drugs further enhance the chances of BCC as the immune system is compromised. White people are more vulnerable to BCC comparatively, according to a research published in the British Medical Journal. The symptoms of BCCs include waxy papules (slightly transparent bump) with pearly appearance and central depression and bleeding from the papules.
The increase in geriatric population, giving rise to numerous skin diseases, such as actinic keratosis and other non-melanoma skin malignancies, is another important factor that has been fueling the demand for basal cell carcinoma treatment substantially. In addition to these, the market is expected to gain considerably from the changing lifestyle of people in developing economies over the coming years as it is anticipated to drive demand for better disease treatments, which in turn, is likely to provide lucrative opportunities for the companies operating in the global basal cell carcinoma treatment market. North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa are considered as the prominent geographical segments of this market. North America, which is the current market leader, is expected to remain dominant over the next few years. The presence of a well-established medical and healthcare infrastructure, increasing expenditure on healthcare, and the high prevalence of basal cell carcinoma in this region are likely to boost the growth of the market for basal cell carcinoma treatment in North America.
The report details the trend, potential and market size of Basal Cell Carcinoma Therapeutics market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Basal Cell Carcinoma Therapeuticsmarket, defines the market attractiveness level of Basal Cell Carcinoma Therapeutics market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Basal Cell Carcinoma Therapeutics industry, describes the types of Basal Cell Carcinoma Therapeutics market, the applications of major players and the market size, and deeply analyzes the current situation of the global Basal Cell Carcinoma Therapeutics market and the development prospects and opportunities of Basal Cell Carcinoma Therapeutics industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Basal Cell Carcinoma Therapeutics market in Chapter 13.
By Player:
Меrсk
Valeant Pharmaceuticals International
Sun Pharmaceuticals
Муlаn
F Hoffmann-Lа Rосhе
By Type:
Surgery
Radiation Therapy
Photodynamic Therapy
Drug
By End-User:
Retail Pharmacy
Hospital Pharmacy
Cancer Research Institute
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Basal Cell Carcinoma Therapeutics Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Basal Cell Carcinoma Therapeutics Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Basal Cell Carcinoma Therapeutics Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Basal Cell Carcinoma Therapeutics Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Basal Cell Carcinoma Therapeutics Market Analysis and Outlook to 2022
-
7.1 Global Basal Cell Carcinoma Therapeutics Consumption (2017-2022)
-
7.2 United States Basal Cell Carcinoma Therapeutics Consumption (2017-2022)
-
7.3 Europe Basal Cell Carcinoma Therapeutics Consumption (2017-2022)
-
7.4 China Basal Cell Carcinoma Therapeutics Consumption (2017-2022)
-
7.5 Japan Basal Cell Carcinoma Therapeutics Consumption (2017-2022)
-
7.6 India Basal Cell Carcinoma Therapeutics Consumption (2017-2022)
-
7.7 South Korea Basal Cell Carcinoma Therapeutics Consumption (2017-2022)
8 Region and Country-wise Basal Cell Carcinoma Therapeutics Market Analysis and Outlook to 2028
-
8.1 Global Basal Cell Carcinoma Therapeutics Consumption Forecast (2022-2028)
-
8.2 United States Basal Cell Carcinoma Therapeutics Consumption Forecast (2022-2028)
-
8.3 Europe Basal Cell Carcinoma Therapeutics Consumption Forecast (2022-2028)
-
8.4 China Basal Cell Carcinoma Therapeutics Consumption Forecast (2022-2028)
-
8.5 Japan Basal Cell Carcinoma Therapeutics Consumption Forecast (2022-2028)
-
8.6 India Basal Cell Carcinoma Therapeutics Consumption Forecast (2022-2028)
-
8.7 South Korea Basal Cell Carcinoma Therapeutics Consumption Forecast (2022-2028)
9 Global Basal Cell Carcinoma Therapeutics Market Outlook by Types and Applications to 2022
-
9.1 Global Basal Cell Carcinoma Therapeutics Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Surgery Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Radiation Therapy Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Photodynamic Therapy Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Drug Consumption and Growth Rate (2017-2022)
-
9.2 Global Basal Cell Carcinoma Therapeutics Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Retail Pharmacy Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Hospital Pharmacy Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Cancer Research Institute Consumption and Growth Rate (2017-2022)
10 Global Basal Cell Carcinoma Therapeutics Market Outlook by Types and Applications to 2028
-
10.1 Global Basal Cell Carcinoma Therapeutics Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Surgery Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Radiation Therapy Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Photodynamic Therapy Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Drug Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Basal Cell Carcinoma Therapeutics Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Retail Pharmacy Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Hospital Pharmacy Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Cancer Research Institute Consumption Forecast and Growth Rate (2022-2028)
11 Global Basal Cell Carcinoma Therapeutics Import and Export Analysis (Top 5 Countries)
-
11.1 Global Basal Cell Carcinoma Therapeutics Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Basal Cell Carcinoma Therapeutics Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Basal Cell Carcinoma Therapeutics Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Basal Cell Carcinoma Therapeutics Market Competitive Analysis
-
14.1 Меrсk
-
14.1.1 Меrсk Company Details
-
14.1.2 Меrсk Basal Cell Carcinoma Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Меrсk Basal Cell Carcinoma Therapeutics Product and Service
-
14.2 Valeant Pharmaceuticals International
-
14.2.1 Valeant Pharmaceuticals International Company Details
-
14.2.2 Valeant Pharmaceuticals International Basal Cell Carcinoma Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Valeant Pharmaceuticals International Basal Cell Carcinoma Therapeutics Product and Service
-
14.3 Sun Pharmaceuticals
-
14.3.1 Sun Pharmaceuticals Company Details
-
14.3.2 Sun Pharmaceuticals Basal Cell Carcinoma Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Sun Pharmaceuticals Basal Cell Carcinoma Therapeutics Product and Service
-
14.4 Муlаn
-
14.4.1 Муlаn Company Details
-
14.4.2 Муlаn Basal Cell Carcinoma Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Муlаn Basal Cell Carcinoma Therapeutics Product and Service
-
14.5 F Hoffmann-Lа Rосhе
-
14.5.1 F Hoffmann-Lа Rосhе Company Details
-
14.5.2 F Hoffmann-Lа Rосhе Basal Cell Carcinoma Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 F Hoffmann-Lа Rосhе Basal Cell Carcinoma Therapeutics Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Basal Cell Carcinoma Therapeutics
-
Figure Basal Cell Carcinoma Therapeutics Picture
-
Table Global Basal Cell Carcinoma Therapeutics Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Basal Cell Carcinoma Therapeutics Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Basal Cell Carcinoma Therapeutics Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Basal Cell Carcinoma Therapeutics Consumption by Country (2017-2022)
-
Figure United States Basal Cell Carcinoma Therapeutics Consumption and Growth Rate (2017-2022)
-
Table Europe Basal Cell Carcinoma Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure China Basal Cell Carcinoma Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Japan Basal Cell Carcinoma Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure India Basal Cell Carcinoma Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure South Korea Basal Cell Carcinoma Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Global Basal Cell Carcinoma Therapeutics Consumption Forecast by Country (2022-2028)
-
Figure United States Basal Cell Carcinoma Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Basal Cell Carcinoma Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Basal Cell Carcinoma Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Basal Cell Carcinoma Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Basal Cell Carcinoma Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Basal Cell Carcinoma Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Surgery Consumption and Growth Rate (2017-2022)
-
Figure Global Radiation Therapy Consumption and Growth Rate (2017-2022)
-
Figure Global Photodynamic Therapy Consumption and Growth Rate (2017-2022)
-
Figure Global Drug Consumption and Growth Rate (2017-2022)
-
Figure Global Retail Pharmacy Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Pharmacy Consumption and Growth Rate (2017-2022)
-
Figure Global Cancer Research Institute Consumption and Growth Rate (2017-2022)
-
Figure Global Surgery Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Radiation Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Photodynamic Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Retail Pharmacy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Pharmacy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Cancer Research Institute Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Basal Cell Carcinoma Therapeutics Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Basal Cell Carcinoma Therapeutics Export by Region (Top 5 Countries) (2017-2028)
-
Table Меrсk (Foundation Year, Company Profile and etc.)
-
Table Меrсk Basal Cell Carcinoma Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Меrсk Basal Cell Carcinoma Therapeutics Product and Service
-
Table Valeant Pharmaceuticals International (Foundation Year, Company Profile and etc.)
-
Table Valeant Pharmaceuticals International Basal Cell Carcinoma Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Valeant Pharmaceuticals International Basal Cell Carcinoma Therapeutics Product and Service
-
Table Sun Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Sun Pharmaceuticals Basal Cell Carcinoma Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sun Pharmaceuticals Basal Cell Carcinoma Therapeutics Product and Service
-
Table Муlаn (Foundation Year, Company Profile and etc.)
-
Table Муlаn Basal Cell Carcinoma Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Муlаn Basal Cell Carcinoma Therapeutics Product and Service
-
Table F Hoffmann-Lа Rосhе (Foundation Year, Company Profile and etc.)
-
Table F Hoffmann-Lа Rосhе Basal Cell Carcinoma Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table F Hoffmann-Lа Rосhе Basal Cell Carcinoma Therapeutics Product and Service
-
